Altamira Therapeutics Ltd. Contributions To Plan By Plan Participants Net Defined Benefit Liability Asset
Altamira Therapeutics Ltd. (CYTOF) reported Contributions To Plan By Plan Participants Net Defined Benefit Liability Asset of $147.42 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset · last filed 2025-04-30
CHF
| Period end | Contributions To Plan By Plan Participants Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2023-12-31 | 130.88K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 154.12K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 101.07K CHF 20-F · filed 2023-05-16 |
| 2020-12-31 | 76.03K CHF 20-F · filed 2022-04-12 |
| 2019-12-31 | 107.62K CHF 20-F · filed 2021-03-31 |
| 2018-12-31 | 146.25K CHF 20-F · filed 2020-04-16 |
USD
| Period end | Contributions To Plan By Plan Participants Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2024-12-31 | $147.42K 20-F · filed 2025-04-30 |
| 2023-12-31 | $145.66K 20-F · filed 2025-04-30 |